Endex 50 mg/ml + 37,5 mg/ml suspensie voor oraal gebruik voor schapen
Endex 50 mg/ml + 37,5 mg/ml suspensie voor oraal gebruik voor schapen
Authorised
- Triclabendazole
- Levamisole hydrochloride
Product identification
Medicine name:
Endex 50 mg/ml + 37,5 mg/ml suspensie voor oraal gebruik voor schapen
Active substance:
- Triclabendazole
- Levamisole hydrochloride
Target species:
-
Sheep
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Triclabendazole50.00/milligram(s)1.00millilitre(s)
-
Levamisole hydrochloride37.50/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Sheep
-
Meat and offal42day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AE51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Available in:
-
Netherlands
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Elanco France S.A.S.
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 7978
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 1/08/2025